Capital Markets
LifeTech
Capital's institutional clients value our proprietary research based on
deep domain expertise in the biotechnology and life technology
(air-food-water) sectors. Our Sales and Trading professionals have
long-standing relationships with over 400 institutional accounts and have
an intimate knowledge of our institutionals clients' sector experiences
and objectives.
The capital markets team is experienced in placing offerings with all capital structure and transaction types matched with the appropriate institutional client. Our capital markets professionals are distinguished by their in-depth understanding of the companies and industries on which we focus. Many of our institutional clients have been long-standing investors in transactions that we have brought to the capital markets and have continued to have a close relationship with us as they have grown in size and assets under management.
In addition, retail investors with our parent, Aurora Capital, and their knowledgeable and experienced registered representatives have unique access to the securities offerings of the investment banking department through our capital markets team.
Capital Markets Team
Robert D. Keyser
CEO LifeTech Capital
& Senior Managing Director of Investment Banking & Capital Markets
Bob@LifeTechCapital.com
Mr. Keyser has over 25 years of experience in all aspects of the securities
industry, having founded several private companies, including Dawson James
Securities, where he was most recently CEO and remains a major shareholder
of its parent company. He has also held various management positions with
several securities firms, including Head of Investment Banking, Capital
Markets, Regional
Sales Manager and Branch Manager, with leadership positions in retail and
institutional sales, operations, underwriting and syndication, compliance
and all general brokerage services. Under Mr. Keyser’s leadership Dawson
James Securities was among the top 25 agents in the country for the last two
years, and was named as one of the top 5 agents in the country for the first
quarter of 2006, as reported by Sagient Research Systems.